Literature DB >> 13679612

Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen.

Han-Chung Wu1, Mei-Ying Jung1, Chien-Yu Chiu1, Ting-Ting Chao1, Szu-Chia Lai2, Jia-Tsrong Jan2, Men-Fang Shaio2.   

Abstract

In this study, a serotype-specific monoclonal antibody (mAb), D(2) 16-1 (Ab4), against dengue virus type 2 (DEN-2) was generated. The specificity of Ab4, which recognized DEN-2 non-structural protein 1, was determined by ELISA, immunofluorescence and immunoblotting analyses. The serotype-specific B-cell epitope of Ab4 was identified further from a random phage-displayed peptide library; selected phage clones reacted specifically with Ab4 and did not react with other mAbs. Immunopositive phage clones displayed a consensus motif, His-Arg/Lys-Leu/Ile, and a synthetic peptide corresponding to the phage-displayed peptide bound specifically to Ab4. The His and Arg residues in this epitope were found to be crucial for peptide binding to Ab4 and binding activity decreased dramatically when these residues were changed to Leu. The epitope-based synthetic peptide not only identified serum samples from DEN-2-immunized mice and rabbits by ELISA but also differentiated clearly between serum samples from DEN-2- and Japanese encephalitis virus-immunized mice. This mAb and its epitope-based peptide antigen will be useful for serologic diagnosis of DEN-2 infection. Furthermore, DEN-2 epitope identification makes it feasible to dissect antibody responses to DEN and to address the role of antibodies in the pathogenesis of primary and secondary DEN-2 infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679612     DOI: 10.1099/vir.0.19228-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus.

Authors:  I-Ju Liu; Chien-Yu Chiu; Yun-Ching Chen; Han-Chung Wu
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

2.  Identification of Dengue-specific B-Cell Epitopes by Phage-display Random Peptide Library.

Authors:  Nevis Amin; Alicia Aguilar; Frank Chamacho; Yaime Vázquez; Maritza Pupo; Juan Carlos Ramirez; Luis Izquierdo; Felix Dafhnis; David Ian Stott; Ela Maria Perez; Armando Acosta
Journal:  Malays J Med Sci       Date:  2009-10

3.  Recombinant multiepitope protein for early detection of dengue infections.

Authors:  Ravulapalli Anandarao; Sathyamangalam Swaminathan; Sirimali Fernando; Asha M Jana; Navin Khanna
Journal:  Clin Vaccine Immunol       Date:  2006-01

4.  Generation and Characterization of Antinonstructural Protein 1 Monoclonal Antibodies and Development of Diagnostics for Dengue Virus Serotype 2.

Authors:  Yin-Liang Tang; I-Ju Liu; Pi-Chun Li; Chien-Yu Chiu; Chun-Yu Lin; Chung-Hao Huang; Yen-Hsu Chen; Chi-Yu Fu; Day-Yu Chao; Chwan-Chuen King; Han-Chung Wu
Journal:  Am J Trop Med Hyg       Date:  2017-07-27       Impact factor: 2.345

5.  Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.

Authors:  Han-Chung Wu; De-Kuan Chang
Journal:  J Oncol       Date:  2010-05-05       Impact factor: 4.375

6.  Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors.

Authors:  De-Kuan Chang; Chien-Yu Chiu; Szu-Yao Kuo; Wei-Chuan Lin; Albert Lo; Yi-Ping Wang; Pi-Chun Li; Han-Chung Wu
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

7.  Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens.

Authors:  Yun-Ching Chen; Hsien-Neng Huang; Chin-Tarng Lin; Yi-Fang Chen; Chwan-Chuen King; Han-Chung Wu
Journal:  Clin Vaccine Immunol       Date:  2007-02-07

8.  A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein.

Authors:  Yong-Qiang Deng; Jian-Xin Dai; Guang-Hui Ji; Tao Jiang; Hua-Jing Wang; Hai-ou Yang; Weng-Long Tan; Ran Liu; Man Yu; Bao-Xue Ge; Qing-Yu Zhu; E-De Qin; Ya-Jun Guo; Cheng-Feng Qin
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

9.  Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 (DENV-3).

Authors:  Andréa N M Rangel da Silva; Eduardo J M Nascimento; Marli Tenório Cordeiro; Laura H V G Gil; Frederico G C Abath; Silvia M L Montenegro; Ernesto T A Marques
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

10.  Development of a humanized antibody with high therapeutic potential against dengue virus type 2.

Authors:  Pi-Chun Li; Mei-Ying Liao; Ping-Chang Cheng; Jian-Jong Liang; I-Ju Liu; Chien-Yu Chiu; Yi-Ling Lin; Gwong-Jen J Chang; Han-Chung Wu
Journal:  PLoS Negl Trop Dis       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.